Jeffrey Apter is at the 15th Clinical Trials on Alzheimer’s Disease (CTAD) in San Francisco, CA this week. If you are attending or in the area, please contact Jeff at to schedule a meeting!

GCT has over 20 years of experience in CNS and Psychiatry and has conducted numerous clinical trials in Alzheimer’s Disease. Our knowledge will be a valuable asset in supporting Pharma and Biotech companies focused on this neurodegenerative disease.